Moderna Inc.

Pfizer Vaccine Effective From Day 11 Post 1st Dose, Study Finds

  • New Australian research suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may not increase vaccine efficacy against SARS-CoV-2.
  • The results suggest one dose of the vaccine could be sufficient in providing a robust immune response 11 days after inoculation.
  • The findings could help shape policy as vaccine rollout has been slow in countries such as the United States and Canada.

A team of researchers suggests that one dose of the Pfizer-BioNTech vaccine could be sufficient in...

https://mfame.guru/pfizer-vaccine-effective-from-day-11-post-1st-dose-study-finds/

COVID-19 Vaccine Allergic Reactions Under Investigation

Moderna Inc said on Tuesday it had received a report from California’s health department that several people at a center in San Diego were treated for possible allergic reactions to its COVID-19 vaccine from a particular batch, says an article published by reuters.

Reactions under investigation

The company’s comments come after California’s top epidemiologist on Sunday issued a statement recommending providers pause vaccination from lot no. 41L20A due to possible allergic reactions that are under...

https://mfame.guru/allergic-reactions-to-covid-19-vaccine-under-investigation/

COVID-19 Not Going Away, Likely To Stay Forever: Warns Moderna CEO

  • Stephane Bancel, CEO of COVID-19 vaccine maker Moderna, warned that the virus will be around “forever.”
  • Public health officials and infectious disease experts have said there is a high likelihood that COVID-19 will become an endemic disease.
  • “SARS-CoV-2 is not going away,” Bancel said during a panel discussion at the JPMorgan Healthcare Conference.

Moderna CEO Stephane Bancel has warned that the novel coronavirus might never disappear and there are high chances of it becoming an endemic...

https://mfame.guru/covid-19-not-going-away-likely-to-stay-forever-warns-moderna-ceo/

US Hospitals Anticipate The Approval Of The Second Vaccine

  • COVID-19 hospitalizations rose to record heights for a 19th straight day, with nearly 113,000 coronavirus patients counted in U.S.
  • The virus has claimed over 311,000 lives in the United States to date, and health experts have warned of a deepening crisis this winter.
  • The initial 2.9 million doses of the Pfizer/BioNTech vaccine began shipping on Sunday and were still making their way to hospitals across the country.

An unrelenting U.S. coronavirus surge pushed besieged hospitals further...

https://mfame.guru/us-hospitals-anticipate-the-approval-of-the-second-vaccine/

Oil Prices Soar Amid OPEC Delays & COVID19 Vaccine Hopes

  • Pfizer and Moderna say their COVID-19 vaccine is 95% effective.
  • Saudi Arabia urges OPEC+ to be flexible on output.
  • U.S. crude stocks rise and distillate inventories plunge.

Oil prices firmed by about 1% on Nov 18 on hopes OPEC and its allies will delay a planned increase in oil output and after Pfizer said its COVID-19 vaccine was more effective, reports Reuters.

The market was also supported by a smaller-than-expected increase in U.S. crude stockpiles last week.

COVID vaccine trials successful

Br...

https://mfame.guru/oil-prices-soar-amid-opec-delays-covid19-vaccine-hopes/

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon
By subscribing, you agree with our privacy policy and our terms of service.